Topotecan is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Topotecan Hydrochloride.
Product ID | 71288-127_06f2245d-e8d3-4436-bcfb-6df6123e8119 |
NDC | 71288-127 |
Product Type | Human Prescription Drug |
Proprietary Name | Topotecan |
Generic Name | Topotecan Hydrochloride |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2019-09-02 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA201166 |
Labeler Name | Meitheal Pharmaceuticals Inc. |
Substance Name | TOPOTECAN HYDROCHLORIDE |
Active Ingredient Strength | 4 mg/15mL |
Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-09-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA201166 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-09-02 |
Ingredient | Strength |
---|---|
TOPOTECAN HYDROCHLORIDE | 4 mg/15mL |
SPL SET ID: | 207ee628-1a7a-4949-bab2-07b9d79b72a3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-0302 | Topotecan | TOPOTECAN |
0703-4714 | Topotecan | Topotecan |
16729-243 | Topotecan | Topotecan |
25021-236 | topotecan | topotecan |
50742-404 | Topotecan | Topotecan |
66758-051 | Topotecan | Topotecan |
67457-662 | TOPOTECAN | TOPOTECAN |
71288-127 | Topotecan | Topotecan |
0078-0672 | HYCAMTIN | topotecan |
0078-0673 | HYCAMTIN | topotecan |
0078-0674 | HYCAMTIN | topotecan hydrochloride |
16729-151 | topotecan hydrochloride | topotecan hydrochloride |
45963-615 | Topotecan hydrochloride | Topotecan hydrochloride |
55390-370 | Topotecan Hydrochloride | Topotecan Hydrochloride |
63323-762 | Topotecan Hydrochloride | TOPOTECAN HYDROCHLORIDE |